Jane Street’s Surmodics SRDX Stock Holding History

Jane Street’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-85,669	Closed	-$2.56M	–	12323
2025 Q3	$2.56M	Buy	85,669 +61,885	+260%	+$2.07M	﹤0.01%	4482
2025 Q2	$707K	Buy	23,784 +4,546	+24%	+$131K	﹤0.01%	6283
2025 Q1	$587K	Buy	+19,238	New	+$648K	﹤0.01%	6568
2024 Q4	–	Sell	-13,459	Closed	-$522K	–	10531
2024 Q3	$522K	Sell	13,459 -7,752	-37%	-$314K	﹤0.01%	7115
2024 Q2	$892K	Buy	+21,211	New	+$724K	﹤0.01%	5980
2023 Q2	–	Sell	-90,401	Closed	-$2.06M	–	9523
2023 Q1	$2.06M	Buy	+90,401	New	+$2.33M	﹤0.01%	3771
2021 Q3	–	Sell	-3,768	Closed	-$204K	–	10684
2021 Q2	$204K	Buy	+3,768	New	+$207K	﹤0.01%	8790

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's SRDX Position: Q4 2025 in Review

Jane Street sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 85,669 shares — an estimated $2.56M sold.

Jane Street first reported a position in SRDX in Q2 2021 and held it in 7 quarters. The position peaked at $2.56M in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Jane Street reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Jane Street sold 85,669 Surmodics shares in Q4 2025, an estimated $2.56M.
Jane Street first reported a position in Surmodics in Q2 2021 and held it in 7 quarters.
Jane Street's Surmodics position peaked at $2.56M in Q3 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.